Double-blind trial of R-(-)-deprenyl for the "on-off" effect complicating Parkinson's disease.

L. I. Golbe, R. C. Duvoisin

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


We performed a double-blind parallel study of deprenyl 5 mg BID vs. placebo in treatment of "on-off" oscillations complicating Parkinson's disease. After a 2-week baseline period, treatment was given for 6 weeks with weekly evaluations using the Northwestern Disability Scale and patients' hourly self-assessment of "on-off" status performed at home. Patients on deprenyl experienced significant improvement in time spent in the "on" state. They were also more likely than patients on placebo to experience improvement of severity of tremor and hypomimia during the "on" state. No other areas of disability improved in quality. Side effects such as hallucinations and worsening of choreoathetosis were frequent among the deprenyl group but generally responded to reduction in concomitant levodopa/carbidopa dosage. We conclude that deprenyl is moderately useful in ameliorating "on-off" in a majority of patients.

Original languageEnglish (US)
Pages (from-to)123-129
Number of pages7
JournalJournal of neural transmission. Supplementum
StatePublished - 1987

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry


Dive into the research topics of 'Double-blind trial of R-(-)-deprenyl for the "on-off" effect complicating Parkinson's disease.'. Together they form a unique fingerprint.

Cite this